Related Experiment Videos
Bronchial Kaposi's sarcoma after single lung transplantation
1Service de Pneumologie et Reánimation Respiratoire, Hôpital Beaujon, Clichy, France.
The European Respiratory Journal
|May 1, 1997
Summary
Kaposi's sarcoma (KS) is rare in lung transplant recipients. This case study details bronchial KS in a patient, successfully treated by reducing immunosuppression, highlighting the need for ongoing monitoring.
Area of Science:
- Oncology
- Transplantation Medicine
- Immunology
Background:
- Kaposi's sarcoma (KS) is a known complication in solid organ transplant recipients, typically occurring in renal allograft recipients.
- While KS is documented in various transplant types, it has not been previously described in lung transplantation.
Observation:
- A case of bronchial Kaposi's sarcoma (KS) is presented in a Black patient six months post-single lung transplantation.
- Notably, the patient had no skin lesions; KS was confined to the trachea and the native lung.
Findings:
- Reduction of the immunosuppressive regimen led to complete remission of bronchial KS within one year.
- This suggests a potential link between immunosuppression levels and KS development in lung transplant recipients.
Implications:
- This case expands the understanding of KS presentation in lung transplant recipients.
- Close surveillance is crucial to monitor for potential KS recurrence or transplant rejection following immunosuppression adjustments.